97 related articles for article (PubMed ID: 10903645)
1. NICE issues guidance for heartburn and indigestion.
Ferriman A
BMJ; 2000 Jul; 321(7255):197. PubMed ID: 10903645
[No Abstract] [Full Text] [Related]
2. [Dyspepsia and heartburn in primary care: a rational and economic approach].
Labenz J
MMW Fortschr Med; 2009 Aug; 151(34-35):47-8. PubMed ID: 19771792
[No Abstract] [Full Text] [Related]
3. Use of non-antacid antiulcer agents in the treatment of heartburn and dyspepsia.
Sena MM; Stoddard ML; Pashko S
Clin Ther; 1994; 16(1):103-9. PubMed ID: 8205596
[TBL] [Abstract][Full Text] [Related]
4. Use of H2-receptor antagonists in patients with dyspepsia and heartburn: a cost comparison.
Goulston KJ; Dent OF; Mant A; Logan J; Ngu M
Med J Aust; 1991 Jul; 155(1):20-6. PubMed ID: 1676825
[TBL] [Abstract][Full Text] [Related]
5. Cost-effective prescribing of proton pump inhibitor therapy: an audit in general practice.
Cooper AL; Langworthy H; Porter S
Int J Clin Pract; 2000 Jun; 54(5):287-92. PubMed ID: 10954954
[TBL] [Abstract][Full Text] [Related]
6. Nonulcer dyspepsia and proton pump inhibitors.
Waldum HL; Martinsen TC; Brenna E
Gastroenterology; 2005 Mar; 128(3):805; author reply 805-6. PubMed ID: 15765429
[No Abstract] [Full Text] [Related]
7. Indigestion remedies.
de Mont A
Community Outlook; 1983 Dec; ():372-3. PubMed ID: 6557888
[No Abstract] [Full Text] [Related]
8. [Gastroenterology in family practice. Updates for your "stomach patient"].
Stiefelhagen P
MMW Fortschr Med; 2006 Jun; 148(22):4-6. PubMed ID: 16821566
[No Abstract] [Full Text] [Related]
9. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
10. OTC omeprazole for your heartburn--enormous value-for-money opportunity.
Curtiss FR
J Manag Care Pharm; 2004; 10(5):458-60. PubMed ID: 15369431
[No Abstract] [Full Text] [Related]
11. Marked increase in proton pump inhibitors use in Australia.
Hollingworth S; Duncan EL; Martin JH
Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):1019-24. PubMed ID: 20623646
[TBL] [Abstract][Full Text] [Related]
12. Absence of pylorus: a rare gastric malformation.
Di Carlo I; Pulvirenti E; Toro A; Di Blasi M
J Am Coll Surg; 2008 Jun; 206(6):1224. PubMed ID: 18501822
[No Abstract] [Full Text] [Related]
13. Heartburn in consumer-directed health care and the cost outcomes of therapeutic maximum allowable cost.
Curtiss FR
J Manag Care Pharm; 2006 Jun; 12(5):402-5; 405. PubMed ID: 16792448
[TBL] [Abstract][Full Text] [Related]
14. PPIs for upper digestive symptoms: EBM does not support empirical practice.
Dumitrascu DL
Rom J Gastroenterol; 2005 Jun; 14(2):203-4; author reply 204-5. PubMed ID: 15990943
[No Abstract] [Full Text] [Related]
15. Pharmacy management methods in Canada, including lower-cost therapy for heartburn.
Jackson M
J Manag Care Pharm; 2006 Jun; 12(5):398-400. PubMed ID: 16792447
[No Abstract] [Full Text] [Related]
16. Early heartburn relief with proton pump inhibitors and the marketing of zegreid.
Graham DY
Clin Gastroenterol Hepatol; 2005 Oct; 3(10):1047; author reply 1047. PubMed ID: 16234053
[No Abstract] [Full Text] [Related]
17. [Heartburn and dyspeptic symptoms. Almost all sour types respond to antacids].
MMW Fortschr Med; 2001 May; 143(20):62-3. PubMed ID: 11400617
[No Abstract] [Full Text] [Related]
18. Cost analysis of a provincial drug program to guide the treatment of upper gastrointestinal disorders.
Bursey F; Crowley M; Janes C; Turner CJ
CMAJ; 2000 Mar; 162(6):817-23. PubMed ID: 10750472
[TBL] [Abstract][Full Text] [Related]
19. Social and medical impact, sleep quality and the pharmaceutical costs of heartburn in Taiwan.
Lu CL; Lang HC; Chang FY; Chen TJ; Chen CY; Luo JC; Lee SD
Aliment Pharmacol Ther; 2005 Oct; 22(8):739-47. PubMed ID: 16197495
[TBL] [Abstract][Full Text] [Related]
20. Review of proton pump inhibitors for the initial treatment of heartburn: is there a dose ceiling effect?
Kushner PR; Peura DA
Adv Ther; 2011 May; 28(5):367-88. PubMed ID: 21484335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
